| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMSA064160 |
| P698 | PubMed publication ID | 17135586 |
| P50 | author | Steven Joffe | Q44378576 |
| Lindsay Hampson | Q57321399 | ||
| Cary P Gross | Q88467914 | ||
| Ezekiel Emanuel | Q5423140 | ||
| P2093 | author name string | Manish Agrawal | |
| Joel Verter | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 2330-2337 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Patients' views on financial conflicts of interest in cancer research trials | |
| P478 | volume | 355 |
| Q38231479 | A systematic review of state and manufacturer physician payment disclosure websites: implications for implementation of the Sunshine Act. |
| Q53098176 | Bias in high-tier medical journals concerning physician-academic relationships with industry. |
| Q88149437 | Closed Financial Loops: When They Happen in Government, They're Called Corruption; in Medicine, They're Just a Footnote |
| Q37142889 | Community hospital oversight of clinical investigators' financial relationships |
| Q55659058 | Conflict of interest among Italian medical oncologists: a national survey. |
| Q58657345 | Conflicts of interest policies for authors, peer reviewers, and editors of bioethics journals |
| Q33332138 | Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents |
| Q37004753 | Correlation between financial relationships with commercial interests and research prominence at an oncology meeting |
| Q58926004 | Disclosing conflicts of interest has unintended effects |
| Q31036751 | Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program |
| Q30532662 | Disclosure of financial conflicts of interest: an evaluation of orthopaedic surgery patients' understanding |
| Q37395133 | Disclosure of financial relationships to participants in clinical research |
| Q39622830 | Distribution and Patterns of Industry-Related Payments to Oncologists in 2014. |
| Q49051838 | Drug reps off campus! Promoting professional purity by suppressing commercial speech |
| Q30783958 | Effect of physician disclosure of specialty bias on patient trust and treatment choice |
| Q36840674 | Effects of disclosing financial interests on attitudes toward clinical research |
| Q34012718 | Effects of disclosing financial interests on participation in medical research: a randomized vignette trial |
| Q37791240 | Ethical considerations in clinical training, care and research in psychopharmacology |
| Q36757557 | Ethical issues concerning therapeutic studies in inflammatory bowel disease |
| Q92213794 | Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study |
| Q39648143 | Here Comes the Sunshine: Industry's Payments to Cardiothoracic Surgeons |
| Q47950892 | Is it really all about the money? Reconsidering non-financial interests in medical research |
| Q34044626 | Key personnel and "long distance" settings: determining who must report financial conflict of interest. |
| Q36111491 | Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review |
| Q47428670 | Medical industry at tumor board: Three-years analysis of the open payments database and comparison of oncologic specialties. |
| Q38044479 | Medical misconduct in Hong Kong: implications for medical education around the world. |
| Q33499060 | More regulation of industry-supported biomedical research: are we asking the right questions? |
| Q36979510 | National evaluation of policies on individual financial conflicts of interest in Canadian academic health science centers |
| Q45264651 | Nothing to declare: mandatory and voluntary disclosure leads advisors to avoid conflicts of interest. |
| Q37455013 | Opinions of IRB Members and Chairs Regarding Investigators' Relationships with Industry. |
| Q33790942 | Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings |
| Q33938276 | Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness |
| Q48070626 | Patient informed choice for altruism |
| Q48048038 | Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics |
| Q36143127 | Patient views on financial relationships between surgeons and surgical device manufacturers |
| Q33584724 | Perceived conflict of interest in health science partnerships |
| Q28552099 | Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs |
| Q35652889 | Psychiatry: from interest in conflicts to conflicts of interest |
| Q38925837 | Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey. |
| Q33874709 | Public perceptions of physician - pharmaceutical industry interactions: a systematic review |
| Q38649519 | Should disclosure of conflicts of interest in medicine be made public? Medical students' views |
| Q53065419 | The Death of Jesse Gelsinger: New Evidence of the Influence of Money and Prestige in Human Research |
| Q48071182 | The Influence of Disclosure and Ethics Education on Perceptions of Financial Conflicts of Interest |
| Q35214096 | The Physician Payments Sunshine Act: data evaluation regarding payments to ophthalmologists |
| Q47584720 | Transparency in Research and its Effect on the Perception of Research Integrity |
| Q39063299 | Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies |
| Q35180409 | What adolescents enrolled in genomic addiction research want to know about conflicts of interest |
| Q34287204 | What potential research participants want to know about research: a systematic review. |
Search more.